<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: “The exemption of customs duty on rare disease drugs was already announced earlier as per court order, but without price caps, these treatments remain out of reach for most patients,” said Prasanna Shirol, Co-founder and Executive Director of Organization for Rare Diseases India.	</title>
	<atom:link href="https://prasannashirol.com/activities/the-exemption-of-customs-duty-on-rare-disease-drugs-was-already-announced-earlier-as-per-court-order-but-without-price-caps-these-treatments-remain-out-of-reach-for-most-patients/feed/" rel="self" type="application/rss+xml" />
	<link>https://prasannashirol.com/activities/the-exemption-of-customs-duty-on-rare-disease-drugs-was-already-announced-earlier-as-per-court-order-but-without-price-caps-these-treatments-remain-out-of-reach-for-most-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-exemption-of-customs-duty-on-rare-disease-drugs-was-already-announced-earlier-as-per-court-order-but-without-price-caps-these-treatments-remain-out-of-reach-for-most-patients</link>
	<description>Rare Disease Advocate, Co-founder &#38; Director - ORDI</description>
	<lastBuildDate>Sun, 02 Feb 2025 03:46:49 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
